Literature DB >> 1377414

Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library.

D Ginsburg1, P L Bockenstedt, E A Allen, D A Fox, P A Foster, Z M Ruggeri, T S Zimmerman, R R Montgomery, W F Bahou, T A Johnson.   

Abstract

A recombinant human von Willebrand factor (vWF) cDNA fragment library was constructed in lambda gt11 for the localization of anti-vWF monoclonal antibody epitopes. Twelve of 21 monoclonal antibodies screened identified epitopes expressed in lambda gt11 as beta-galactosidase fusion proteins. By sequence analysis, these antigenic determinants were localized to segments ranging from 17 to 105 amino acids in length. Four epitopes apparently shared by more than one antibody were identified, suggesting the presence of immuno-dominant epitopes within vWF. Monoclonal antibody C3, which blocks factor VIII (FVIII) binding to vWF, bound to the same epitope previously identified by a second monoclonal antibody which also blocks this function, suggesting that this region may be at or near the vWF/FVIII binding domain. Three antibodies recognize the same region within the vWF A2 repeat. Mutations near this region appear to be responsible for Type IIA von Willebrand's disease. The co-localization of these antibodies suggests that this domain might be exposed on the surface of vWF, consistent with its apparent increased sensitivity to plasma proteases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377414

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.

Authors:  Roberta Donadelli; Jennifer N Orje; Cristina Capoferri; Giuseppe Remuzzi; Zaverio M Ruggeri
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

2.  CD6 is a target for cancer immunotherapy.

Authors:  Jeffrey H Ruth; Mikel Gurrea-Rubio; Kalana S Athukorala; Stephanie M Rasmussen; Daniel P Weber; Peggy M Randon; Rosemary J Gedert; Matthew E Lind; M Asif Amin; Phillip L Campbell; Pei-Suen Tsou; Yang Mao-Draayer; Qi Wu; Thomas M Lanigan; Venkateshwar G Keshamouni; Nora G Singer; Feng Lin; David A Fox
Journal:  JCI Insight       Date:  2021-03-08

3.  What a polyclonal antibody sees in von Willebrand factor.

Authors:  Fen-Lai Tan; David Ginsburg
Journal:  Thromb Res       Date:  2007-07-05       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.